150 related articles for article (PubMed ID: 15990982)
1. Efficacy of pazufloxacin mesilate in Legionnaires' disease: a case report and in vitro study of the isolate.
Higa F; Shinzato T; Toyama M; Haranaga S; Furugen M; Tateyama M; Kawakami K; Saito A
J Infect Chemother; 2005 Jun; 11(3):164-8. PubMed ID: 15990982
[TBL] [Abstract][Full Text] [Related]
2. In vivo efficacy of sivelestat in combination with pazufloxacin against Legionella pneumonia.
Morinaga Y; Yanagihara K; Araki N; Yamada K; Seki M; Izumikawa K; Kakeya H; Yamamoto Y; Yamada Y; Kohno S; Kamihira S
Exp Lung Res; 2010 Oct; 36(8):484-90. PubMed ID: 20939755
[TBL] [Abstract][Full Text] [Related]
3. Legionnaires' disease after a campervan holiday: a case report.
Euser SM; Diederen BM; Bakker M; Honing ML; Bruin JP; Brandsema PS; Reijnen L; Den Boer JW
J Travel Med; 2016 Jan; 23(1):. PubMed ID: 26782124
[TBL] [Abstract][Full Text] [Related]
4. [A travel abroad-associated case of Legionella pneumonia diagnosed by urinary antigen detection test].
Ishii Y; Bando M; Ohno S; Sugiyama Y
Kansenshogaku Zasshi; 2005 Apr; 79(4):290-3. PubMed ID: 15977568
[TBL] [Abstract][Full Text] [Related]
5. Severe Legionnaires' disease successfully treated using a combination of fluoroquinolone, erythromycin, corticosteroid, and sivelestat.
Kakeya H; Ehara N; Fukushima K; Seki M; Izumikawa K; Yamamoto Y; Yanagihara K; Saito A; Kohno S
Intern Med; 2008; 47(8):773-7. PubMed ID: 18421197
[TBL] [Abstract][Full Text] [Related]
6. The clinical efficacy of fluoroquinolone and macrolide combination therapy compared with single-agent therapy against community-acquired pneumonia caused by Legionella pneumophila.
Nakamura S; Yanagihara K; Izumikawa K; Seki M; Kakeya H; Yamamoto Y; Senjyu H; Saito A; Kohno S
J Infect; 2009 Sep; 59(3):222-4. PubMed ID: 19592113
[No Abstract] [Full Text] [Related]
7. [Pneumonia due to Legionella pneumophila in an immunocompromised child].
van Dijk K; Kamphuis S; Geelen SP; Wulffraat NM; van Gestel JP; Wolfs TF
Ned Tijdschr Geneeskd; 2002 Jul; 146(30):1420-3. PubMed ID: 12174438
[TBL] [Abstract][Full Text] [Related]
8. [A case of legionellesis pneumonia verified by isolation of Legionella pneumophila serogroup 1 from bronchoalveolar lavage fluid treated with levofloxacine and tigecycline].
Galstian GM; Drokov MIu; Katrysh SA; Kliasova GA; Giliazitdinova EA; Karpova TI; Marakusha BI; Tartakovskiĭ IS
Ter Arkh; 2011; 83(7):61-5. PubMed ID: 21894754
[TBL] [Abstract][Full Text] [Related]
9. Treatment strategies for Legionella infection.
Pedro-Botet ML; Yu VL
Expert Opin Pharmacother; 2009 May; 10(7):1109-21. PubMed ID: 19405787
[TBL] [Abstract][Full Text] [Related]
10. [Legionnaires disease (legionella pneumonia)].
Dobrick N; Müller N; Franzen D
Praxis (Bern 1994); 2012 Nov; 101(23):1459-65; quiz 1466-7. PubMed ID: 23147600
[No Abstract] [Full Text] [Related]
11. Current clinical management of Legionnaires' disease.
Garcia-Vidal C; Carratalà J
Expert Rev Anti Infect Ther; 2006 Dec; 4(6):995-1004. PubMed ID: 17181416
[TBL] [Abstract][Full Text] [Related]
12. A case of pneumonia caused by Legionella pneumophila serogroup 12 and treated successfully with imipenem.
Nishizuka M; Suzuki H; Ara T; Watanabe M; Morita M; Sato C; Tsuchida F; Seto J; Amemura-Maekawa J; Kura F; Takeda H
J Infect Chemother; 2014 Jun; 20(6):390-3. PubMed ID: 24629522
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Legionnaires' disease.
Amsden GW
Drugs; 2005; 65(5):605-14. PubMed ID: 15748096
[TBL] [Abstract][Full Text] [Related]
14. Legionella pneumonia caused by Legionella pneumophila serogroup 2: second case report in Japan.
Furugen M; Koide M; Baba M; Sato Y; Teruya H; Naha Y; Tamayose M; Akamine M; Uchihara T; Atsumi E; Haranaga S; Yara S; Higa F; Tateyama M; Fujita J
J Infect Chemother; 2008 Apr; 14(2):161-5. PubMed ID: 18622682
[TBL] [Abstract][Full Text] [Related]
15. The Diagnosis of Legionella pneumophila Serogroup 5 Bacteremic Pneumonia during Severe Neutropenia Using Loop-mediated Isothermal Amplification.
Moriguchi S; Abe M; Kimura M; Yoshino C; Baba M; Okada C; Izutsu K; Taniguchi S; Araoka H; Yoneyama A
Intern Med; 2018 Apr; 57(7):1045-1048. PubMed ID: 29269681
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial chemotherapy for legionnaires' disease: a review.
Edelstein PH
Clin Infect Dis; 1995 Dec; 21 Suppl 3():S265-76. PubMed ID: 8749675
[TBL] [Abstract][Full Text] [Related]
17. Persistently positive culture results in a patient with community-acquired pneumonia due to Legionella pneumophila.
Tan JS; File TM; DiPersio JR; DiPersio LP; Hamor R; Saravolatz LD; Stout JE
Clin Infect Dis; 2001 Jun; 32(11):1562-6. PubMed ID: 11340527
[TBL] [Abstract][Full Text] [Related]
18.
Dubois J; Dubois M; Martel JF
Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32094130
[TBL] [Abstract][Full Text] [Related]
19. [A patient with Legionella pneumophila serogroup-3 pneumonia, detected by PCR].
Herpers BL; Bossink AW; Cohen Stuart JW; Hustinx WN; Thijsen SF
Ned Tijdschr Geneeskd; 2005 Sep; 149(36):2009-12. PubMed ID: 16171114
[TBL] [Abstract][Full Text] [Related]
20. Imipenem therapy for Legionnaires' disease.
Edelstein PH
J Infect Chemother; 2015 Jan; 21(1):76. PubMed ID: 25443312
[No Abstract] [Full Text] [Related]
[Next] [New Search]